ScreenerHero
SCPScope Fluidics S.A.Partial data
GPW · PL · Healthcare · Diagnostics & Research · scopefluidics.com
136.60PLN-0.29%Mkt Cap: 109.93M $P/E: —

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. It offers BacterOMIC, an antibiotic susceptibility testing. …

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.64BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMerieux S.A.
$9.51BUSDP/E 19.0
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap109.93M $
Enterprise Value73.09M $
Revenue (TTM)26.34K $
Gross Profit-921.36K $
Net Income (TTM)-11.74M $
Revenue/Share0.0081 USD
Last Price136.60 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees157
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISINPLSCPFL00018
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-5.75
EV/Revenue2775.08
P/S4124.84
P/B2.88
EPS (TTM)-16.96
EPS (Forward)—
52W Range
109.0038% of range182.20
52W High182.20 PLN
52W Low109.00 PLN
Profitability
Gross Margin-3638.00%
Oper. Margin-53814.82%
EBITDA Margin0.00%
Profit Margin-46364.00%
ROE-28.54%
ROA-23.66%
Growth
Revenue Growth17.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.68M $
CapEx (TTM)3.39M $
FCF Margin-43984.38%
FCF Yield-10.54%
Net Debt-34.43M $
Net Debt/EBITDA2.71
Balance Sheet
Debt/Equity0.01
Current Ratio11.81
Quick Ratio11.20
Book Value/Sh47.02 PLN
Cash/Share43.63 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMar 24, 2023
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)223.90 PLN
Upside (mean)+63.9%
Target Range223.90 PLN – 223.90 PLN
# Analysts1
Ownership
Shares Out.3.17M
Float1.89M
Insiders22.85%
Institutions17.76%
Technical
SMA 50123.84 (+10.3%)
SMA 200136.23 (+0.3%)
Beta0.00
S&P 52W Chg19.97%
Avg Vol (30d)1.39K
Avg Vol (10d)1.97K
Technical Indicators
RSI (14)69.8
MACD1.2124
MACD Signal-0.4627
MACD Hist.+1.6751
BB Upper133.38 PLN
BB Middle123.26 PLN
BB Lower113.14 PLN
BB Width16.42%
ATR (14)4.496 PLN
Vol Ratio (20d)1.46x